TY - JOUR
T1 - Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency
AU - Hisamoto, Akiko
AU - Yamane, Hiromichi
AU - Hiraki, Akio
AU - Maeda, Yoshinobu
AU - Fujii, Nobuharu
AU - Sasaki, Kenji
AU - Miyake, Toshitugu
AU - Sasaki, Takashi
AU - Nakamura, Tohru
AU - Kiura, Katsuyuki
AU - Tanimoto, Mitsune
AU - Kamei, Haruhito
PY - 2003/11
Y1 - 2003/11
N2 - Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.
AB - Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.
KW - Common variable immunodeficiency
KW - Human herpes virus 8
KW - Non-Hodgkin's lymphoma
KW - Primary effusion lymphoma
UR - http://www.scopus.com/inward/record.url?scp=10744219773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10744219773&partnerID=8YFLogxK
U2 - 10.1080/1042819031000110955
DO - 10.1080/1042819031000110955
M3 - Article
C2 - 14738159
AN - SCOPUS:10744219773
SN - 1042-8194
VL - 44
SP - 2019
EP - 2022
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 11
ER -
